Labiotech.eu

News and Trends 3 Jul 2020

CRISPR Therapeutics Announces Huge €400M Public Fundraise

The Swiss firm CRISPR Therapeutics has priced a public offering on the Nasdaq Global Market at around €400M, which it will use to develop therapies based on the gene editing tool CRISPR/Cas9 for genetic disorders and cancer. This fundraise is the second-highest global share offering from a European biotech so far this year after the […]

July 3, 2020 - 2 minutesmins - By Laura Cowen

News and Trends 3 Jul 2020

Pfizer-BioNTech Covid-19 Vaccine Shows Phase I Promise

A vaccine made out of messenger RNA (mRNA), developed by the US pharmaceutical giant Pfizer and its German partner BioNTech, has produced antibodies against the Covid-19 pathogen in healthy volunteers. The results come from an interim analysis of an ongoing phase I clinical trial in 45 participants. So far, all test subjects who received two […]

July 3, 2020 - 3 minutesmins - By Victor Kotsev

News and Trends 2 Jul 2020

Freeline Closes €106M Series C to Progress Hemophilia Gene Therapy

UK biotech Freeline Therapeutics has extended its Series C round to take its gene therapy for hemophilia B to a pivotal trial, while hinting at the possibility of an IPO in the US later this year. This final closing adds an additional €70M to a €36M Series C investment by London-based VC Syncona in December […]

July 2, 2020 - 3 minutesmins - By Helen Albert

Reports 2 Jul 2020

Guidelines for Biotechs: Managing Risks in Biological Drug Development

Navigating the complexity of the industry can be highly challenging for early-stage biotechs focusing on biological drug development. Once they have a robust strategy in place and have chosen a suitable partner, biotechs face other hurdles in upstream process development, manufacturing, IND filing, and regulatory processes. Discover how to address challenges and manage risks throughout […]

July 2, 2020 - 2 minutesmins - By Larissa Warneck-Silvestrin

sonoran desert toad psychedelic beckley psytech

News and Trends 1 Jul 2020

UK Startup Bags €3M to Develop Psychedelic Medicines for Mental Health

A €3.3M (£3M) Series A round raised by the Oxford-based biomedicine company Beckley Psytech will allow the company to study the use of a psychedelic compound for the treatment of mental health disorders and neuropsychiatric disease. The investors include the UK VC firms Mediqventures and Jamjar Investments, which was set up by Richard Reed, co-founder […]

July 1, 2020 - 3 minutesmins - By Kostas Vavitsas

News and Trends 1 Jul 2020

Swiss Regenerative Medicine Biotech Closes €19M Series B

The regenerative medicine startup Cutiss has raised €18.8M (CHF 20M) to commercialize its personalized skin graft treatment for burn patients in Switzerland and the European Union around 2022. This is the final closing of a Series B round announced earlier this month. The lead investor in the oversubscribed round was the Swiss firm Gisev Family […]

July 1, 2020 - 3 minutesmins - By David Wilson

Expert Advice 1 Jul 2020

Why Biotech Must Change its Cleaning and Disinfection Strategy

Many biotech companies deploy strong chemicals to clean and disinfect their equipment. However, if handled in the wrong way, this can lead to dangerous problems such as antibiotic resistance. As the EU prepares to release new guidelines on good manufacturing practices, it’s time to revise how cleaning is approached in the industry. To effectively control […]

July 1, 2020 - 10 minutesmins - By Melanie Maria Obermeier

News and Trends 30 Jun 2020

Kymab Wins UK Supreme Court Antibody Battle Against Regeneron

The UK Supreme Court has supported an appeal by British biotech Kymab to revoke antibody drug patents held by US giant Regeneron, a decision that could make it harder for big patent holders to clamp down on small innovators in the biotech industry. Kymab and Regeneron have been battling it out in the UK since […]

June 30, 2020 - 4 minutesmins - By Anita Chakraverty

News and Trends 29 Jun 2020

Enterome Secures €46M to Take Microbiome Therapies to Clinical Trials

French microbiome biotech Enterome has raised €46.3M in Series E funding to progress its cancer and inflammatory bowel disease therapies to phase I trials in a few weeks. Two new investors to Enterome — SymBiosis, a US-based investor, and the Japanese big pharma Takeda — took part in the fundraise in addition to existing investors […]

June 29, 2020 - 3 minutesmins - By Helen Albert

News and Trends 29 Jun 2020

Update: Hyloris Raises €62M IPO to Create More Drug Delivery Options

Update (29/06/2020): Hyloris Pharmaceuticals’ Euronext IPO — one of only a handful of biotech and pharma IPOs on European soil in the last 18 months — has hit the midpoint of its expected pricing range with a value of €61.8M. The shares were priced at €10.75 each, which was comfortably between the minimum target of […]

June 29, 2020 - 3 minutesmins - By Jonathan Smith

In Depth 29 Jun 2020

Can Biotechnology Reduce Animal Testing in Medicine?

Animal testing is crucial for measuring the efficacy and safety of new treatments. It’s also a step that everyone would like to avoid as much as possible for economic, regulatory, and ethical reasons. But what are the alternatives, and can they really reduce the use of animals in drug development? Before drug developers let a […]

June 29, 2020 - 8 minutesmins - By Jonathan Smith

News and Trends 26 Jun 2020

UK Loosens Controls on GW’s Cannabinoid Epilepsy Drug

A cannabinoid medication marketed by GW Pharmaceuticals for the treatment of severe forms of epilepsy will be more easily available to patients in the UK after the drug was moved to the least strict classification by the country’s Home Office. The medication — branded as Epidyolex in the EU and Epidiolex in the US — […]

June 26, 2020 - 4 minutesmins - By Victor Kotsev

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

CRISPR Therapeutics Announces Huge €400M Public Fundraise

Pfizer-BioNTech Covid-19 Vaccine Shows Phase I Promise

Freeline Closes €106M Series C to Progress Hemophilia Gene Therapy

Guidelines for Biotechs: Managing Risks in Biological Drug Development

UK Startup Bags €3M to Develop Psychedelic Medicines for Mental Health

Swiss Regenerative Medicine Biotech Closes €19M Series B

Why Biotech Must Change its Cleaning and Disinfection Strategy

Kymab Wins UK Supreme Court Antibody Battle Against Regeneron

Enterome Secures €46M to Take Microbiome Therapies to Clinical Trials

Update: Hyloris Raises €62M IPO to Create More Drug Delivery Options

Can Biotechnology Reduce Animal Testing in Medicine?

UK Loosens Controls on GW’s Cannabinoid Epilepsy Drug

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!